Interventional Pain Procedures
Interventional pain procedures provide diagnostic information and therapeutic benefit for chronic pain conditions when conservative management fails. Epidural steroid injection (ESI): Indicated for radicular pain from...
Clinical board
A visual summary of the highest-yield teaching signals on this page.
Urgent signals
Safety-critical features pulled from the topic metadata.
- Infection at injection site
- Vascular injection causing systemic toxicity
- Neural injury with new neurological deficit
- Pneumothorax after thoracic procedures
Exam focus
Current exam surfaces linked to this topic.
- ANZCA Final Written
- ANZCA Final Clinical Viva
Editorial and exam context
Quick Answer
Interventional pain procedures provide diagnostic information and therapeutic benefit for chronic pain conditions when conservative management fails. Epidural steroid injection (ESI): Indicated for radicular pain from disc herniation or spinal stenosis, using fluoroscopic guidance, interlaminar or transforaminal approach, triamcinolone 40-80 mg or methylprednisolone 80 mg with local anaesthetic; 50-70% response rate, duration 3-6 months, maximum 3-4 injections per year. Facet joint injection and medial branch block: For axial back pain with positive diagnostic block (>80% pain relief), using 1-2 mL local anaesthetic ± steroid; radiofrequency ablation (RFA) of medial branches provides 6-12 months pain relief for 60-70% patients. Sacroiliac joint injection: For SI joint pain (positive Fortin finger test, pain below L5), 1-2 mL steroid + local; RFA of lateral branches if diagnostic block positive. Peripheral nerve blocks: Diagnostic (prognostic for neurolysis/neurectomy) or therapeutic (repetitive blocks for CRPS); examples: occipital nerve block (headache), suprascapular nerve block (shoulder pain), genicular nerve block (knee OA). Spinal cord stimulation (SCS): Indicated for FBSS (failed back surgery syndrome), CRPS, refractory angina; trial period 3-7 days, permanent implant if >50% pain reduction; complications: lead migration (10%), infection (5%), hardware failure. Intrathecal drug delivery: For refractory cancer or non-cancer pain; morphine, ziconotide, baclofen; complications: infection, granuloma formation, catheter failure. Contraindications: Coagulopathy (INR >1.4, platelets <100), infection, patient refusal, allergic to contrast. Complications: Bleeding, infection (1-2%), nerve injury (<1%), intravascular injection (systemic toxicity), pneumothorax (thoracic procedures), spinal cord injury. Indigenous patients may have limited access to interventional pain services due to geography; telehealth screening and prioritized referral pathways important. [1-10]